HBI Awards 2018: Urine tests at home using smartphones

Healthy.io takes smartphone cameras into clinical quality medical scanners, using colour recognition and AI data sets to create a product for existing healthcare systems.

Its first test kit is Dip.io, which digitizes urinalysis, the second most common diagnostic test, particularly useful in prenatal health and chronic kidney disease. The solution increases access to testing and by eliminating the need to travel to a lab and can be used in any setting at a low cost. Images are sent directly to the doctor, reducing wait time.

Full application

1. Briefly describe the organisation giving number of facilities, staff, revenue numbers.
Healthy.io is the first company to have turned the smartphone into a regulatory approved medical device. They take existing smartphone cameras and use computer vision and machine learning to turn them into clinical grade scanners. Dip.io is the only regulatory approved device for digital urine testing in the market. Healthy.io was founded in 2013 by Yonatan Adiri. It has offices in Tel Aviv and UK and currently employs around 25 employees.

2. What is the nature of the service in which the organisation is using digital health?
Healthy.io is a company turning smartphone cameras into clinical quality medical scanners, using color recognition and AI data sets to create a product for existing healthcare systems. Today, centralized medical testing is only offered at a lab or point of care and requires a certified trained professional, which reduces the chances of early detection and preventative screenings. Testing, while necessary for people of all backgrounds, can also become unaffordable. Healthy.io wants to capitalize on the generational smartphone trend present across all different types of populations, regardless of demographic. They are introducing a new reality, making clinical quality healthcare as simple as taking a selfie, because everyone deserves accessible and affordable treatment. The kit is provided to consumers through their healthcare systems, since it is a B2B company, but is administered at home.

3. What is the nature of the digital health offering? Please describe the main IP component of this service.
Healthy.io is an innovative company that identifies a clinical opportunity, relevant to a large number of people, that is ready for digitization and develops a smartphone-enables solution using AI, computer vision and user centered design, and take it through a regulatory process and scale it for mass adoption. For this innovation, Dip.io, Healthy.io aimed to digitize urinalysis. Urinalysis is the second most common diagnostics test offering an existing >$10bn global market. Urinalysis is critical to detect common urinary tract infections, a critical tool in prenatal health and key to reducing the $99bn spend on chronic kidney disease in the US alone.

Healthy.io offers health-providers an end-to-end service that digitizes urinalysis in relevant clinical pathways, improving their efficiency and value through a digital at-home urinalysis solution. Billions of patients require urine testing every year. With Dip.io they no longer need to rely on a centralized laboratory but can conduct the test in the comfort of their home, improving adherence and overall outcomes. Through its unique IP of machine learning and algorithms, Healthy.io is the first company to have turned the smartphone camera into a regulatory approved medical device, with no additional hardware needed. This allows for a low cost solution to medical testing and easy scaleability.

4. When did the organisation start delivering this service en masse?
Month : January
Year : 2016

5. What are the main key performance indicators? How does the organisation measure the success of the project?
Healthy.io and the Dip.io solution work together with healthcare organizations to improve efficiency, value and outcomes by digitizing existing pathways. KPIs include clinical guideline adherence, usability and cost improvements. Some of the current successful digitized pathways are:
Pregnancy- Through quality and patient-centered care, Healthy.io puts emphasis on improved monitoring to at-risk pregnancies by providing additional testing that is available to the physician in real time. Less than 10% of pregnant women favored traditional testing at a doctor compared to home testing with a smartphone.

Chronic Kidney Disease (CKD) screening- Healthy.io increases adherence of ACT testing for the early identification and management of CKD in at-risk populations such as diabetes and hypertension. Currently there is a low adherence to the yearly testing of these populations, a digitized pathway aims to increase adherence to improve CKD outcomes and associated costs.

Urinary Tract Infection (UTI) – The Dip.io solution aims to decrease GP appointments and A&E admissions while decreasing antimicrobial resistance due to over prescribed antibiotics with no prior testing.

6. How has the digital health enabled service impacted on patient/care recipient outcomes?
Healthy.io has already made strides in efforts to digitize old-fashioned clinical cases with its urinalysis system, in terms of UTI in patients with neurological conditions, antenatal care in pregnancy and ACR testing for early identification and management of CKD.

Over 100,000 people in the UK live with MS and 127,000 suffer from Parkinson’s disease.
Patients with Neurological conditions are at a high risk of developing urinary tract infections, it is estimated that three in ten MS patients suffer from regular UTI (MS Trust). UTIs often lead to avoidable hospitalization, costing the NHS $2,000 per patient per episode.

The Dip.io solution enables neurological patients to test their urine for bacterial infection with clinical accuracy. They get the results immediately, instead of having to wait 2-3 days for a response from the lab. Healthy.io provides local partners with a customized kit, a localized app and integrates into the existing patient record. Data can easily be shared with a neurology nurse or caregiver, who gets notified when a UTI is detected, and appropriate treatment started without delay. Empowering people to test themselves reduces unnecessary hospital admissions to the benefit of the patient and the health system.

In a Johns Hopkins study done by Healthy.io for 150 pregnant women in the Baltimore area.

7. Addition Documents
Brochure 1
Brochure 2
Brochure 3
Brochure 4
Brochure 5

We would welcome your thoughts on this story. Email your views to Zhasmina Simeonova or call 0207 183 3779.